Injection of CAR-T cells reverses asthma in mice
Chinese researchers have designed an asthma treatment based on CAR-T cells. A single injection of these cells, modified to attack the eosinophils themselves - a type of white blood cell that is activated by certain infections and allergies - achieved remission of the signs and symptoms of the disease for at least a year in mice. According to the authors, the technique will need to be tested in human clinical trials, but could be useful for treating both asthma and other types of allergies. The results are published in the journal Nature Immunology.